BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan WPW, Mourad F, Leong RW. Crohn's disease associated strictures. J Gastroenterol Hepatol. 2018;33:998-1008. [PMID: 29427364 DOI: 10.1111/jgh.14119] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Malick A, Shen B. Endoscopic Treatment of Postoperative Bleeding, Bezoars, and Foreign Bodies. Gastrointestinal Endoscopy Clinics of North America 2022;32:829-43. [DOI: 10.1016/j.giec.2022.05.008] [Reference Citation Analysis]
2 Ladrón Abia P, Alonso N, Mínguez Sabater A, Gimeno Torres M, Bastida G, Aguas M, Beltrán B, Sáez-gonzález E, Pons V, Nos P, Iborra M. The characteristics of the stricture, but not the ongoing treatment, could influence the outcome of endoscopic dilation in recurrent Crohn's disease. Gastroenterología y Hepatología (English Edition) 2022;45:614-620. [DOI: 10.1016/j.gastre.2022.01.005] [Reference Citation Analysis]
3 Xu W, Hua Z, Wang Y, Gu Y, Zhong J, Cui L, Du P. The endoscopic prediction model of simple endoscopic score for Crohn’s disease (SES-CD) as an effective predictor of intestinal obstruction in Crohn’s disease: A multicenter long-term follow-up study. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.984029] [Reference Citation Analysis]
4 Ye Y, Zhang X, Su D, Ren Y, Cheng F, Yao Y, Shi G, Ji Y, Chen S, Shi P, Dai L, Su X, Deng H. Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn's colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling. Stem Cell Res Ther 2022;13:465. [PMID: 36076306 DOI: 10.1186/s13287-022-03157-8] [Reference Citation Analysis]
5 Sivasailam B, Lane BF, Cross RK. Endoscopic Balloon Dilation of Strictures. Gastrointestinal Endoscopy Clinics of North America 2022. [DOI: 10.1016/j.giec.2022.04.006] [Reference Citation Analysis]
6 Wewer MD, Karstensen JG, Burisch J. Endoscopic small bowel balloon dilations in patients with Crohn's disease: a Danish nationwide cohort study, 1997-2015. Eur J Gastroenterol Hepatol 2022. [PMID: 35694802 DOI: 10.1097/MEG.0000000000002390] [Reference Citation Analysis]
7 Wang Y, Wang Z, Yang H, Chen S, Zheng D, Liu X, Jiang Q, Chen Y. Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-β1/Smad3 Signaling. Front Pharmacol 2022;13:887497. [DOI: 10.3389/fphar.2022.887497] [Reference Citation Analysis]
8 Chen BC, Weng MT, Chang CH, Huang LY, Wei SC. Effect of smoking on the development and outcomes of inflammatory bowel disease in Taiwan: a hospital-based cohort study. Sci Rep 2022;12:7665. [PMID: 35538186 DOI: 10.1038/s41598-022-11860-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang Z, Zhou H, Cheng F, Zhang Z, Long S. MiR-21 regulates epithelial–mesenchymal transition in intestinal fibrosis of Crohn's disease by targeting PTEN/mTOR. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.04.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignaß A, Ehehalt R, Germer C, Grunert PC, Helwig U, Herrlinger K, Kienle P, Kreis ME, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators:. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Z Gastroenterol 2022;60:332-418. [PMID: 35263784 DOI: 10.1055/a-1713-3941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
11 Bushara O, Escobar DJ, Weinberg SE, Sun L, Liao J, Yang GY. The Possible Pathogenic Role of IgG4-Producing Plasmablasts in Stricturing Crohn's Disease. Pathobiology 2022;:1-11. [PMID: 35026755 DOI: 10.1159/000521259] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Amarapurkar AD. Grossing Techniques of Gastrointestinal Tract Specimens: Benign. Surgical Pathology of the Gastrointestinal System 2022. [DOI: 10.1007/978-981-16-6395-6_4] [Reference Citation Analysis]
13 Vedula SV, Nickerson TP, Grider DJ. A Novel Cause of Bowel Obstruction in a Patient with Long-Standing Crohn's Disease. Case Rep Pathol 2021;2021:3278392. [PMID: 34707913 DOI: 10.1155/2021/3278392] [Reference Citation Analysis]
14 Bali A, Rani M. Recent Advances in Diagnosis and Management of Crohn’s Disease. Crohn’s Disease Recent Advances 2021. [DOI: 10.5772/intechopen.97693] [Reference Citation Analysis]
15 Narula N, Wong ECL, Dulai PS, Marshall JK, Colombel JF, Reinisch W. Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis. J Crohns Colitis 2021;15:1649-57. [PMID: 33693522 DOI: 10.1093/ecco-jcc/jjab045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Minordi LM, Bevere A, Papa A, Larosa L, Manfredi R. CT and MRI Evaluations in Crohn's Complications: A Guide for the Radiologist. Acad Radiol 2021:S1076-6332(21)00354-8. [PMID: 34583864 DOI: 10.1016/j.acra.2021.07.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Unterweger AL, Rüscher A, Seuß M, Winkelmann P, Beigel F, Koletzko L, Breiteneicher S, Siebeck M, Gropp R, Aszodi A. NOD/scid IL-2Rγnull mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype. Immun Inflamm Dis 2021. [PMID: 34499803 DOI: 10.1002/iid3.516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Grażyńska A, Kufel J, Dudek A, Cebula M. Shear Wave and Strain Elastography in Crohn's Disease-A Systematic Review. Diagnostics (Basel) 2021;11:1609. [PMID: 34573952 DOI: 10.3390/diagnostics11091609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Wang R, Wang D, Wang H, Wang T, Weng Y, Zhang Y, Luo Y, Lu Y, Wang Y. Therapeutic Targeting of Nrf2 Signaling by Maggot Extracts Ameliorates Inflammation-Associated Intestinal Fibrosis in Chronic DSS-Induced Colitis. Front Immunol 2021;12:670159. [PMID: 34456904 DOI: 10.3389/fimmu.2021.670159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
20 Ueno A, Jijon HB, Peng R, Sparksman S, Mainoli B, Filyk A, Li Y, Wilson S, Novak K, Panaccione R, Hirota S, Dufour A, Lu C, Beck PL. Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn's Disease. Inflamm Bowel Dis 2021:izab157. [PMID: 34428284 DOI: 10.1093/ibd/izab157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Zhao J, Liao D, Wilkens R, Krogh K, Glerup H, Gregersen H. Bowel stiffness associated with histopathologic scoring of stenosis in patients with Crohn's disease. Acta Biomater 2021;130:332-42. [PMID: 34119715 DOI: 10.1016/j.actbio.2021.06.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
22 Shivaji UN, Evans M, Critchlow T, Gui X, Smith SCL, Pinkney T, Iacucci M, Cooney R, Ghosh S, Skordilis K. Chronic inflammation and other changes are significant components of clinically fibrotic strictures in Crohn's disease: a histological study of resected strictures clinically characterized as noninflamed. Eur J Gastroenterol Hepatol 2020;32:1432-9. [PMID: 32639416 DOI: 10.1097/MEG.0000000000001796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Schmidt C, Bachmann O, Baumgart DC, Goetz M, Drvarov O, Kucharzik TF, Kühbacher T, Langhorst J, Maul J, Mohl W, Mudter J, Repp M, Sturm A, Witzemann D, Atreya R. [Position paper on endoscopic reporting in IBD]. Z Gastroenterol 2021. [PMID: 34284522 DOI: 10.1055/a-1504-9782] [Reference Citation Analysis]
24 Lin XX, Qiu Y, Zhuang XJ, Liu F, Wu XM, Chen MH, Mao R. Intestinal stricture in Crohn's disease: A 2020 update. J Dig Dis 2021;22:390-8. [PMID: 34014617 DOI: 10.1111/1751-2980.13022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Bury MI, Fuller NJ, Clemons TD, Sturm RM, Morrison CD, Lisy‐snow DC, Nolan BG, Tarczynski C, Ayello EMT, Boyce A, Muckian B, Ahmad N, Hunter CJ, Karver MR, Stupp SI, Sharma AK. Self‐Assembling Nanofibers Inhibit Inflammation in a Murine Model of Crohn's‐Disease‐Like Ileitis. Adv Therap 2021;4:2000274. [DOI: 10.1002/adtp.202000274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Cicero G, Ascenti G, Blandino A, Trimarchi R, Booz C, Vogl TJ, D'Angelo T, Mazziotti S. Elective surgery outcomes in inflammatory bowel disease: interpretation at magnetic resonance enterography. Jpn J Radiol 2021;39:633-41. [PMID: 33624159 DOI: 10.1007/s11604-021-01103-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Mainenti PP, Castiglione F, Rispo A, Laccetti E, Guarino S, Romeo V, Testa A, Pace L, Maurea S. MR-enterography in Crohn's disease: what MRE mural parameters are associated to one-year therapeutic management outcome? Br J Radiol 2021;94:20200844. [PMID: 33186053 DOI: 10.1259/bjr.20200844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Collyer R, Clancy A, Agrawal G, Borody TJ. Crohn’s strictures open with anti-mycobacterial antibiotic therapy: A retrospective review. World J Gastrointest Endosc 2020; 12(12): 542-554 [PMID: 33362907 DOI: 10.4253/wjge.v12.i12.542] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Zhou LY, Lin SN, Rieder F, Chen MH, Zhang SH, Mao R. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside. Inflamm Bowel Dis 2021;27:971-82. [PMID: 33324986 DOI: 10.1093/ibd/izaa321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Steiner CA, Rodansky ES, Johnson LA, Berinstein JA, Cushing KC, Huang S, Spence JR, Higgins PDR. AXL Is a Potential Target for the Treatment of Intestinal Fibrosis. Inflamm Bowel Dis 2021;27:303-16. [PMID: 32676663 DOI: 10.1093/ibd/izaa169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
31 Wang J, Ortiz C, Fontenot L, Xie Y, Ho W, Mattai SA, Shih DQ, Koon HW. High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures. PLoS One 2020;15:e0231796. [PMID: 32287314 DOI: 10.1371/journal.pone.0231796] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
32 Crespi M, Dulbecco P, De Ceglie A, Conio M. Strictures in Crohn's Disease: From Pathophysiology to Treatment. Dig Dis Sci 2020;65:1904-16. [PMID: 32279173 DOI: 10.1007/s10620-020-06227-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
33 Yoo JH, Holubar S, Rieder F. Fibrostenotic strictures in Crohn's disease. Intest Res 2020;18:379-401. [PMID: 32259917 DOI: 10.5217/ir.2019.09148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
34 Wu F, Shao Q, Hu M, Zhao Y, Dong R, Fang K, Xu L, Zou X, Lu F, Li J, Chen G. Wu-Mei-Wan ameliorates chronic colitis-associated intestinal fibrosis through inhibiting fibroblast activation. J Ethnopharmacol 2020;252:112580. [PMID: 31972322 DOI: 10.1016/j.jep.2020.112580] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
35 Chang CW, Tu CH, Chou JW, Huang TY, Hsu WH, Wang YP, Chen CC, Chung CS, Lin CP, Lin WC, Tai CM, Wang HY, Chen MJ. Endoscopic management of strictures in patients with Crohn's disease - A multi-center experience in Taiwan. J Formos Med Assoc 2020;119:1500-5. [PMID: 31917065 DOI: 10.1016/j.jfma.2019.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
36 Bokemeyer A, Tepasse PR, Quill L, Lenz P, Rijcken E, Vieth M, Ding N, Ketelhut S, Rieder F, Kemper B, Bettenworth D. Quantitative Phase Imaging Using Digital Holographic Microscopy Reliably Assesses Morphology and Reflects Elastic Properties of Fibrotic Intestinal Tissue. Sci Rep 2019;9:19388. [PMID: 31852983 DOI: 10.1038/s41598-019-56045-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
37 Grass F, Fletcher JG, Alsughayer A, Petersen M, Bruining DH, Bartlett DJ, Mathis KL, Lightner AL. Development of an Objective Model to Define Near-Term Risk of Ileocecal Resection in Patients with Terminal Ileal Crohn Disease. Inflammatory Bowel Diseases 2019;25:1845-53. [DOI: 10.1093/ibd/izz079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
38 Crews NR, Bohm ME. Complications of Inflammatory Bowel Disease: Initial Medical Management and Role of Endoscopy. Multidisciplinary Approaches to Common Surgical Problems 2019. [DOI: 10.1007/978-3-030-12823-4_12] [Reference Citation Analysis]
39 Ishihara KB, Mayo J, Gillern S. Inflammatory Bowel Disease. Multidisciplinary Approaches to Common Surgical Problems 2019. [DOI: 10.1007/978-3-030-12823-4_13] [Reference Citation Analysis]
40 Petrucciani N, de’Angelis N, Gaiani F, Brunetti F. Colorectal Cancer Surgical Emergencies in Patients with Inflammatory Bowel Disease. Emergency Surgical Management of Colorectal Cancer 2019. [DOI: 10.1007/978-3-030-06225-5_18] [Reference Citation Analysis]
41 Núñez-gómez L, Mesonero-gismero F, Albillos-martínez A, López-sanromán A. Anti-tumour necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease. Gastroenterología y Hepatología (English Edition) 2018;41:576-582. [DOI: 10.1016/j.gastre.2018.06.014] [Reference Citation Analysis]
42 Sarani B, Paspulati RM, Hambley J, Efron D, Martinez J, Perez A, Bowles-Cintron R, Yi F, Hill S, Meyer D, Maykel J, Attalla S, Kochman M, Steele S. A multidisciplinary approach to diagnosis and management of bowel obstruction. Curr Probl Surg 2018;55:394-438. [PMID: 30526888 DOI: 10.1067/j.cpsurg.2018.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Núñez-Gómez L, Mesonero-Gismero F, Albillos-Martínez A, López-Sanromán A. Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease. Gastroenterol Hepatol 2018;41:576-82. [PMID: 30054143 DOI: 10.1016/j.gastrohep.2018.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
44 Rubín de Célix Vargas C, Martín García P, del Campo L, García-buey L. String sign of Kantor in a patient with Crohn�s disease. Rev Esp Enferm Dig 2018;110. [DOI: 10.17235/reed.2018.5598/2018] [Reference Citation Analysis]